Valsartan differs from ramipril in the following respect:: (A) It does not potentiate bradykinin, (B) It can be safely administered to a patient with bilateral renal artery stenosis, (C) It impairs carbohydrate tolerance, (D) It does not have fetopathic potential
Answer is A. None